Results 61 to 70 of about 2,198,200 (198)
Tracking the Evolution of Non‐Small‐Cell Lung Cancer
New England Journal of Medicine, 2017 BACKGROUND Among patients with non‐small‐cell lung cancer (NSCLC), data on intratumor heterogeneity and cancer genome evolution have been limited to small retrospective cohorts.M. Jamal-Hanjani, G. Wilson, N. Mcgranahan, Nicolai J. Birkbak, T. Watkins, S. Veeriah, S. Shafi, Diana H. Johnson, R. Mitter, R. Rosenthal, M. Salm, S. Horswell, M. Escudero, Nik Matthews, A. Rowan, T. Chambers, D. Moore, S. Turajlic, Hang Xu, S. Lee, M. Forster, T. Ahmad, C. Hiley, C. Abbosh, M. Falzon, E. Borg, T. Marafioti, D. Lawrence, M. Hayward, S. Kolvekar, N. Panagiotopoulos, S. Janes, R. Thakrar, Asia Ahmed, F. Blackhall, Y. Summers, R. Shah, L. Joseph, A. Quinn, P. Crosbie, B. Naidu, G. Middleton, G. Langman, S. Trotter, M. Nicolson, H. Remmen, K. Kerr, M. Chetty, L. Gomersall, D. Fennell, A. Nakas, S. Rathinam, G. Anand, S. Khan, P. Russell, V. Ezhil, Babikir Ismail, Melanie Irvin-sellers, V. Prakash, J. Lester, M. Kornaszewska, R. Attanoos, Haydn Adams, H. Davies, S. Dentro, P. Tanière, Brendan O’Sullivan, H. Lowe, J. Hartley, N. Iles, Harriet Bell, Y. Ngai, J. Shaw, Javier Herrero, Z. Szallasi, R. Schwarz, A. Stewart, S. Quezada, J. Le Quesne, P. Van Loo, C. Dive, A. Hackshaw, C. Swanton +82 moresemanticscholar +1 more sourceFactors modulating 99mTc‐MAA planar lung dosimetry for 90Y radioembolization
Journal of Applied Clinical Medical Physics, Volume 23, Issue 12, December 2022., 2022 Abstract Purpose
To investigate the accuracy and biases of predicted lung shunt fraction (LSF) and lung dose (LD) calculations via 99mTc‐macro‐aggregated albumin (99mTc‐MAA) planar imaging for treatment planning of 90Y‐microsphere radioembolization.Benjamin P. Lopez, Armeen Mahvash, James P. Long, Marnix G. E. H. Lam, S. Cheenu Kappadath +4 morewiley +1 more sourceComprehensive genomic characterization of squamous cell lung cancers
Nature, 2012 Lung squamous cell carcinoma is a common type of lung cancer, causing approximately 400,000 deaths per year worldwide. Genomic alterations in squamous cell lung cancers have not been comprehensively characterized, and no molecularly targeted agents have ...P. Hammerman, Douglas Voet, M. Lawrence, Douglas Voet, R. Jing, K. Cibulskis, A. Sivachenko, P. Stojanov, A. McKenna, E. Lander, S. Gabriel, G. Getz, M. Imieliński, E. Helman, Bryan Hernandez, Nam Pho, M. Meyerson, Andy Chu, Jung E. Hye-Chun, A. Mungall, E. Pleasance, A. G. Robertson, Payal Sipahimalani, D. Stoll, M. Balasundaram, I. Birol, Y. Butterfield, E. Chuah, R. Coope, R. Corbett, Noreen Dhalla, R. Guin, A. He, Carrie Hirst, M. Hirst, R. Holt, Darlene Lee, H. Li, Michael Mayo, Richard A. Moore, K. Mungall, K. Nip, A. Olshen, J. Schein, Jared R. Slobodan, Angela Tam, N. Thiessen, R. Varhol, Thomas Zeng, Yongjun Zhao, Steven J. M. Jones, M. Marra, G. Saksena, A. Cherniack, S. Schumacher, B. Tabak, S. Carter, Huy L. Nguyen, R. Onofrio, A. Crenshaw, K. Ardlie, R. Beroukhim, W. Winckler, A. Protopopov, Jianhua Zhang, Angela Hadjipanayis, Semin Lee, Ruibin Xi, Lixing Yang, X. Ren, Hailei Zhang, S. Shukla, Peng-Chieh Chen, Psalm S. Haseley, E. Lee, L. Chin, P. Park, R. Kucherlapati, N. Socci, Yupu Liang, N. Schultz, L. Borsu, A. Lash, A. Viale, C. Sander, M. Ladanyi, J. Auman, K. Hoadley, M. Wilkerson, Yan Shi, C. Liquori, S. Meng, Ling Li, Yidi J. Turman, M. D. Topal, Donghui Tan, S. Waring, Elizabeth Buda, Jesse L. Walsh, Corbin D. Jones, P. Mieczkowski, Darshan Singh, Junyuan Wu, Anisha Gulabani, Peter Dolina, T. Bodenheimer, A. Hoyle, J. Simons, Matthew G. Soloway, Joshua M. Stuart, Lisle E. Mose, S. Jefferys, S. Balu, Brian D. O’Connor, Derek Y. Chiang, Jinze Liu, D. Hayes, C. Perou, L. Cope, D. Weisenberger, Ludmila V. Danilova, D. Weisenberger, D. Maglinte, F. Pan, D. V. Berg, T. Triche, J. Herman, S. Baylin, P. Laird, M. Noble, Nils Gehlenborg, D. Dicara, Jinhua Zhang, Chang-Jiun Wu, Spring Yingchun Liu, L. Zou, Pei Lin, Juok Cho, Marc-Danie Nazaire, James Robinson, H. Thorvaldsdóttir, J. Mesirov, Rileen Sinha, G. Ciriello, E. Cerami, Benjamin E. Gross, A. Jacobsen, Jianjiong Gao, B. A. Aksoy, Nils Weinhold, Ricardo Ramirez, B. Taylor, Yevgeniy Antipin, B. Reva, Qianxing Mo, V. Seshan, P. Paik, Rehan Akbani, Nianxiang Zhang, B. Broom, Tod D. Casasent, A. Unruh, Chris Wakefield, R. Cason, K. Baggerly, J. Weinstein, D. Haussler, C. Benz, Jingchun Zhu, C. Szeto, G. Scott, C. Yau, S. Ng, Theodore Goldstein, Peter Waltman, Artem Sokolov, E. Collisson, K. Ellrott, D. Zerbino, Singer Ma, Brian Craft, Ying Du, Christopher R. Cabanski, Vonn Walter, J. Marron, Yufeng Liu, Kai Wang, J. Prins, C. Creighton, Yiqun Zhang, W. Travis, N. Rekhtman, Joanne E. Yi, M. Aubry, R. Cheney, S. Dacic, D. Flieder, W. Funkhouser, P. Illei, J. Myers, M. Tsao, R. Penny, D. Mallery, T. Shelton, M. Hatfield, S. Morris, P. Yena, C. Shelton, M. Sherman, J. Paulauskis, R. Govindan, I. Azodo, D. Beer, R. Bose, L. Byers, D. Carbone, Li-Wei Chang, Elizabeth Chun, L. Ding, J. Heymach, C. Ida, B. Johnson, I. Jurisica, J. Kaufman, F. Kosari, D. Kwiatkowski, C. Maher, A. Mungall, W. Pao, M. Peifer, Gordon Robertson, V. Rusch, J. Siegfried, C. Sougnez, Roman K. Thomas, S. Tomaszek, Charles J. Vaske, D. Wheeler, D. Wigle, C. Wilks, J. Zhang, M. Jensen, R. Sfeir, A. Kahn, A. Chu, Prachi Kothiyal, Zhining Wang, E. Snyder, J. Pontius, T. Pihl, Brenda Ayala, M. Backus, Jessica L Walton, J. Baboud, D. Berton, M. Nicholls, Deepak Srinivasan, R. Raman, Stanley Girshik, Peter A. Kigonya, S. Alonso, Rashmi N. Sanbhadti, S. Barletta, J. Greene, D. Pot, B. Bandarchi-Chamkhaleh, J. Boyd, J. Weaver, I. Azodo, C. Ida, Ping Yang, M. Brock, K. Rogers, M. Rutledge, T. Brown, Beverly Lee, James Shin, D. Trusty, R. Dhir, O. Potapova, K. Fedosenko, Elena Nemirovich-Danchenko, M. Zakowski, M. Iacocca, Jennifer Brown, B. Rabeno, Christine Czerwinski, N. Petrelli, Zhen Fan, N. Todaro, J. Eckman, W. Rathmell, L. Thorne, Meijuan Huang, L. Boice, Ashley D. Hill, Erin E. Curley, C. Morrison, Carmelo Gaudioso, J. Bartlett, S. Kodeeswaran, B. Zanke, H. Sekhon, K. David, H. Juhl, X. Le, B. Kohl, Richard A. Thorp, N. V. Tien, N. V. Bang, H. Sussman, Bui Duc Phu, R. Hajek, N. P. Hung, K. Z. Khan, T. Muley, K. Shaw, Margi Sheth, Liming Yang, K. Buetow, Tanja Davidsen, John A. Demchok, G. Eley, M. Ferguson, Laura A. L. Dillon, C. Schaefer, M. Guyer, B. Ozenberger, Jacqueline D. Palchik, Jane L. Peterson, H. Sofia, E. Thomson, R. Shen +332 moresemanticscholar +1 more sourceInhibition of acyl‐CoA synthetase long‐chain isozymes decreases multiple myeloma cell proliferation and causes mitochondrial dysfunction
Molecular Oncology, EarlyView.Triacsin C inhibition of the acyl‐CoA synthetase long chain (ACSL) family decreases multiple myeloma cell survival, proliferation, mitochondrial respiration, and membrane potential. Made with Biorender.com. Multiple myeloma (MM) is an incurable cancer of plasma cells with a 5‐year survival rate of 59%.Connor S. Murphy, Heather Fairfield, Victoria E. DeMambro, Samaa Fadel, Carlos A. Gartner, Michelle Karam, Christian Potts, Princess Rodriguez, Ya‐Wei Qiang, Habib Hamidi, Xiangnan Guan, Calvin P. H. Vary, Michaela R. Reagan +12 morewiley +1 more sourceFeasibility of radical cardiac‐sparing, treatment planning strategies for patients with locally advanced, non‐small cell lung cancer
Journal of Applied Clinical Medical Physics, Volume 23, Issue 12, December 2022., 2022 Abstract Purpose
A set of treatment planning strategies were designed and retrospectively implemented for locally advanced, non‐small cell lung cancer (NSCLC) patients in order to minimize cardiac dose without compromising target coverage goals. Methods
Retrospective analysis was performed for 20 NSCLC patients prescribed to 60–66 Gy that received a ...Joshua P. Kim, Jake Dewalt, Aharon Feldman, Khaled Adil, Benjamin Movsas, Indrin J. Chetty +5 morewiley +1 more sourceCell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
Molecular Oncology, EarlyView.mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor Khrystany T. Isebia, Anouk C. de Jong, Lisanne F. van Dessel, Vanja de Weerd, Corine Beaufort, Jean Helmijr, José Alberto Nakauma‐González, Job van Riet, Paul Hamberg, Daniel Vis, Michiel S. van der Heijden, Nick Beije, Martijn P. Lolkema, Teoman Deger, Saskia M. Wilting, Ronald de Wit, Maurice P. H. M. Jansen, John W. M. Martens +17 morewiley +1 more source